Pneumonia News

The Healio Editors compiled the most-read news in pulmonology posted in April.

Two widely used clinical scoring systems — the Pneumonia Severity Index and CURB-65 score — comparatively predicted in-hospital mortality in patients with and without SARS-CoV-2-related community-acquired pneumonia, researchers reported.

Long-term CT abnormalities were common up to 1 year after COVID-19 pneumonia in a study published in Radiology.

Pulse oximeter measurements of blood oxygen levels appear to be unreliable to assess the severity of COVID-19 pneumonia across different ethnicities, according to new data published in the European Respiratory Journal.

In a new study, all asthma phenotypes were associated with risk for more severe COVID-19 outcomes, except for type 2 inflammation, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

From 2007 to 2018, hospitalizations for respiratory failure increased, while respiratory failure-related mortality declined among individuals with sarcoidosis, according to data published in Chest.

Colchicine fails to significantly reduce mechanical ventilation or 28-day mortality in hospitalized patients with COVID-19 pneumonia, compared with usual care, according to data published in JAMA Network Open.

The Healio Editors compiled the most-read news in pulmonology posted in December.

Lenzilumab significantly improved survival without the need for invasive mechanical ventilation among patients hospitalized with COVID-19, according to results of the LIVE-AIR trial published in The Lancet Respiratory Medicine.

Convalescent plasma failed to reduce progression to severe respiratory failure or death within 30 days in patients with moderate to severe COVID-19 pneumonia, according to a new study published in JAMA Network Open.